JenaValve Appoints Dave Haan as Vice President of Clinical Affairs
IRVINE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve...
IRVINE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve...
New Advisory Board and Cross-Sector Model Signal Growing Demand for Innovation Designed for Real-World Implementation EMERYVILLE, CA / ACCESS Newswire...
Vancouver, Canada, May 12, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech...
~ Patent Extends Jurisdiction and Protection Through 2042 ~ SAN DIEGO, CA / ACCESS Newswire / May 12, 2026 /...
Grant program expands access to advanced single-domain antibody technologies to support the research and development of next-generation therapiesBOSTON and LONDON,...
ENvue™ Navigation Platform adopted as the standard of care for bedside feeding tube placement across the integrated health networkTYLER, Texas,...
"As Federal Courts Review Cannabis Policy and CMS Expands Cannabinoid Access, MMJ's FDA-and-DEA-Compliant Pharmaceutical Track Record Emerges as a Potential...
Patent reinforces strategic foundation for lead ADC AKTX-101 and expanding ADC pipeline to new molecules targeting high-value oncology indicationsTAMPA, Fla....
Dr. Karli Provost Goldstein, Dr. Leigh Rosen, and Dr. Amanda Chu honored for excellence in patient‑centered gynecologic care MANHATTAN, NY...
Patented Algorithm Designed to Help Identify Otherwise Dangerous Prostate Tumors Earlier Using Repeat Blood Test Results Licensing Agreement Expands 20/20...
The FDA Authorizes Fruit-Flavored Vapes for Adults 21 and Up Nationwide. CBD Vapes Market size was valued at US$ 5.8...
Disseminated on behalf of SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) and may include paid advertising. NEW YORK, May 12,...
SAN DIEGO and SUZHOU, China, May 12, 2026 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming...
Orchestra BioMed targeting enrollment completion of BACKBEAT Global Pivotal Trial (“BACKBEAT Trial”) by the end of Q3 2026 Orchestra BioMed and...
THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that Company management will participate...
NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement...
Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. NEW YORK, May 12,...
The first‑in‑class antibody program is designed to selectively target pathogenic cells, with the potential to deliver deeper and more durable...
- Distinguished vascular surgeon brings decades of clinical experience, innovation, and leadership to new role at cutting-edge biotech manufacturer -...
Second Positive DSMB Review Supports Continued Study Progress Interim Phase 3 Results Support Ovaprene’s Differentiation as a First-in-Category, Hormone-Free, Intravaginal...